Overview
- API Holdings completed repayment of ₹1,050 crore in outstanding debt, closing a refinancing cycle that began with a proposed NCD issue in September 2025.
- Docon Technologies sold about 9.90% of Thyrocare’s paid-up equity in market trades and retained a 51.02% holding that is now unencumbered.
- The company says the repayment was funded by proceeds from the Thyrocare share sale together with internal accruals, and that all pledges linked to the debt have been released.
- Thyrocare reported stronger operating results for Q1 FY27 with operating revenue of ₹240.02 crore and net profit of ₹52.19 crore, figures company management cites as enabling the balance-sheet cleanup.
- With the pledge removed and leverage eliminated, API Holdings says it will shift focus to profitable growth and disciplined capital allocation, a change that could affect investor views on governance and liquidity risk.